Literature DB >> 22611120

Mass spectrometry of apolipoprotein C-III, a simple analytical method for mucin-type O-glycosylation and its application to an autosomal recessive cutis laxa type-2 (ARCL2) patient.

Yoshinao Wada1, Machiko Kadoya, Nobuhiko Okamoto.   

Abstract

Apolipoprotein C-III (apoCIII) is a small glycoprotein with a single mucin-type core-1 oligosaccharide and is analyzed by isoelectric focusing (IEF) for the diagnosis of genetic defects in O-glycan biosynthesis such as congenital disorders of glycosylation. In the present study, mass spectrometry of apoCIII, after a simple procedure for sample preparation using a small amount of serum, was demonstrated to be a reliable alternative to IEF. It allows reproducible glycan profiling and detection of unglycosylated species. This method was applied to an autosomal recessive cutis laxa type-2 patient and demonstrated decreased site occupancy by O-glycosylation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22611120     DOI: 10.1093/glycob/cws086

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  13 in total

1.  TMEM165 Deficiency: Postnatal Changes in Glycosylation.

Authors:  S Schulte Althoff; M Grüneberg; J Reunert; J H Park; S Rust; C Mühlhausen; Y Wada; R Santer; T Marquardt
Journal:  JIMD Rep       Date:  2015-08-04

Review 2.  Mass spectrometric immunoassays for discovery, screening and quantification of clinically relevant proteoforms.

Authors:  Olgica Trenchevska; Randall W Nelson; Dobrin Nedelkov
Journal:  Bioanalysis       Date:  2016-07-11       Impact factor: 2.681

3.  Development of multiplex mass spectrometric immunoassay for detection and quantification of apolipoproteins C-I, C-II, C-III and their proteoforms.

Authors:  Olgica Trenchevska; Matthew R Schaab; Randall W Nelson; Dobrin Nedelkov
Journal:  Methods       Date:  2015-03-07       Impact factor: 3.608

Review 4.  Mass spectrometry of transferrin and apolipoprotein C-III for diagnosis and screening of congenital disorder of glycosylation.

Authors:  Yoshinao Wada
Journal:  Glycoconj J       Date:  2016-02-13       Impact factor: 2.916

5.  In-Depth Site-Specific O-Glycosylation Analysis of Glycoproteins and Endogenous Peptides in Cerebrospinal Fluid (CSF) from Healthy Individuals, Mild Cognitive Impairment (MCI), and Alzheimer's Disease (AD) Patients.

Authors:  Zhengwei Chen; Danqing Wang; Qing Yu; Jillian Johnson; Richard Shipman; Xiaofang Zhong; Junfeng Huang; Qinying Yu; Henrik Zetterberg; Sanjay Asthana; Cynthia Carlsson; Ozioma Okonkwo; Lingjun Li
Journal:  ACS Chem Biol       Date:  2021-12-29       Impact factor: 4.634

6.  LC-MS/MS identification of the O-glycosylation and hydroxylation of amino acid residues of collagen α-1 (II) chain from bovine cartilage.

Authors:  Ehwang Song; Yehia Mechref
Journal:  J Proteome Res       Date:  2013-07-23       Impact factor: 4.466

7.  Label-free analysis of o-glycosylation site-occupancy based on the signal intensity of glycopeptide/peptide ions.

Authors:  Yoshinao Wada
Journal:  Mass Spectrom (Tokyo)       Date:  2012-11-02

Review 8.  Advances in mass spectrometry-based glycoproteomics.

Authors:  Aiying Yu; Jingfu Zhao; Wenjing Peng; Alireza Banazadeh; Seth D Williamson; Mona Goli; Yifan Huang; Yehia Mechref
Journal:  Electrophoresis       Date:  2018-10-09       Impact factor: 3.535

9.  Glycoproteomics: identifying the glycosylation of prostate specific antigen at normal and high isoelectric points by LC-MS/MS.

Authors:  Ehwang Song; Anoop Mayampurath; Chuan-Yih Yu; Haixu Tang; Yehia Mechref
Journal:  J Proteome Res       Date:  2014-11-10       Impact factor: 4.466

10.  Targeted Measurements of O- and N-Glycopeptides Show That Proteins in High Density Lipoprotein Particles Are Enriched with Specific Glycosylation Compared to Plasma.

Authors:  Muchena J Kailemia; Wanghui Wei; Khoa Nguyen; Elizabeth Beals; Lisa Sawrey-Kubicek; Christopher Rhodes; Chenghao Zhu; Romina Sacchi; Angela M Zivkovic; Carlito B Lebrilla
Journal:  J Proteome Res       Date:  2017-12-27       Impact factor: 4.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.